Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2014 08:31 ET | Source: Fortis Inc.

Fortis Inc. annonce un dividende sur ses actions privilégiées de premier rang de série M pour le quatrième trimestre de 2014

ST. JOHN'S, TERRE-NEUVE-ET-LABRADOR--(Marketwired - 24 sept. 2014) - En plus du dividende annoncé le 14 août 2014, le conseil d'administration de Fortis Inc. («...
September 24, 2014 08:31 ET | Source: Quest Solution, Inc.

Quest Solution, Inc. Named Datamax-O'Neil Premier Partner

HENDERSON, Nev., Sept. 24, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Quest Solution, Inc, "The Company" (OTCBB:QUES), is pleased to announce it has been promoted to Premier Partner status in the...
September 24, 2014 08:30 ET | Source: Sibling Group Holdings, Inc.

Sibling's Blended Schools Network Division Offers Special Education Professional Development for All Educators

AUSTIN, TX--(Marketwired - Sep 24, 2014) - Sibling Group Holdings, Inc. (OTCQB: SIBE), (www.siblinggroup.com) (the "Company"), an educational technology holding company, announced today that it is...
September 24, 2014 08:30 ET | Source: AutoChina International Ltd.

AutoChina International Reports 2014 Second Quarter and Six Month Financial Results, a 48% Increase in Commercial Vehicle Revenues in Second Quarter 2014

SHIJIAZHUANG, CHINA--(Marketwired - Sep 24, 2014) - AutoChina International Limited ("AutoChina" or the "Company") (OTCBB: AUTCF), a leading provider of innovative financing solutions for China's...
September 24, 2014 08:30 ET | Source: Worthington Industries

Worthington Industries Announces First Quarter 2015 Earnings Conference Call

COLUMBUS, Ohio, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Worthington Industries, Inc. (NYSE:WOR) will hold its quarterly earnings conference call on Thursday, Sept. 25, 2014 at 10:30 a.m. Eastern Daylight...
September 24, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy

Met primary efficacy endpoint by successfully restoring testosterone levels to the normal range in 88% of the subjects Lower limit of the 95% confidence interval was 82% 85% of the...
September 24, 2014 08:30 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Announces Phase 1 Funding by the National Institute of Drug Abuse, National Institutes of Health, Under the Small Business Innovation Research Funding Award Program

GLEN ROCK, N.J., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, including drug-induced...
September 24, 2014 08:30 ET | Source: Protea Biosciences, Inc.

USDA Acquires Protea's LAESI(R) Technology Platform

MORGANTOWN, W.V., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) ("Protea") announced today that the United States Department of Agriculture (USDA) Agricultural...
September 24, 2014 08:30 ET | Source: Medgenics, Inc.

Medgenics to Announce Third Quarter 2014 Results and Provide Initial Clinical Data on MDGN-201 (EPODURE(TM)) Trial on October 15, 2014

WAYNE, Pa. and MISGAV, Israel, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN) will host a conference call and live audio webcast on Wednesday, October 15, 2014 at 9 a.m. EDT to discuss...
September 24, 2014 08:23 ET | Source: Nasdaq Riga

Exchange announcement on the results of government debt securities primary placement auction

Riga, Latvia, 2014-09-24 14:23 CEST (GLOBE NEWSWIRE) -- ISIN code of the security LV00005 70125 Date of competitive multi-price...

1 ...228568 228569 228570 ...326083